These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32228483)

  • 1. Joint modelling of longitudinal and time-to-event data: an illustration using CD4 count and mortality in a cohort of patients initiated on antiretroviral therapy.
    Mchunu NN; Mwambi HG; Reddy T; Yende-Zuma N; Naidoo K
    BMC Infect Dis; 2020 Mar; 20(1):256. PubMed ID: 32228483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa.
    Hoffmann CJ; Schomaker M; Fox MP; Mutevedzi P; Giddy J; Prozesky H; Wood R; Garone DB; Egger M; Boulle A;
    J Acquir Immune Defic Syndr; 2013 May; 63(1):34-41. PubMed ID: 23344547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.
    Takuva S; Maskew M; Brennan AT; Long L; Sanne I; Fox MP
    J Int AIDS Soc; 2014; 17(1):18651. PubMed ID: 24594114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
    Seyoum A; Ndlovu P; Temesgen Z
    AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive quantile mixed effects modelling with application to longitudinal CD4 count data.
    Yirga AA; Melesse SF; Mwambi HG; Ayele DG
    Sci Rep; 2021 Sep; 11(1):17945. PubMed ID: 34504147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of longitudinal changes of CD4 cell count and survival time to death of HIV/AIDS patients treated at Yabelo General Hospital, the case of pastoralist area: Using joint modelling approach.
    Nura GJ; Guyo AB; Erango MA
    PLoS One; 2024; 19(6):e0305519. PubMed ID: 38913649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using joint models to study the association between CD4 count and the risk of death in TB/HIV data.
    Mchunu NN; Mwambi HG; Rizopoulos D; Reddy T; Yende-Zuma N
    BMC Med Res Methodol; 2022 Nov; 22(1):295. PubMed ID: 36401214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of quantile mixed-effects model in modeling CD4 count from HIV-infected patients in KwaZulu-Natal South Africa.
    Yirga AA; Melesse SF; Mwambi HG; Ayele DG
    BMC Infect Dis; 2022 Jan; 22(1):20. PubMed ID: 34983387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Infect Dis; 2020 Mar; 20(1):246. PubMed ID: 32216755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.
    van Griensven J; Thai S
    Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):694-703. PubMed ID: 21962614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How varying CD4 criteria for treatment initiation was associated with mortality of HIV-patients? A retrospective analysis of electronic health records from Andhra Pradesh, India.
    Bajpai R; Chaturvedi HK; Car J
    J Glob Health; 2020 Jun; 10(1):010408. PubMed ID: 32257156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.
    Rohr JK; Ive P; Horsburgh CR; Berhanu R; Shearer K; Maskew M; Long L; Sanne I; Bassett J; Ebrahim O; Fox MP
    PLoS One; 2016; 11(8):e0161469. PubMed ID: 27548695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling CD4 counts before and after HAART for HIV infected patients in KwaZulu-Natal South Africa.
    Yirga AA; Melesse SF; Mwambi HG; Ayele DG
    Afr Health Sci; 2020 Dec; 20(4):1546-1561. PubMed ID: 34394215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.
    Fwemba I; Musonda P
    Public Health; 2017 Jun; 147():8-14. PubMed ID: 28404502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.